Impact of prior CKD management in a renal care network on early outcomes in incident dialysis patients: a prospective observational study

BMC Nephrology

Maurice Laville⁵  Sophie Fave⁵  Christelle Maurice⁷  François Vrtovsnik⁶  Laurent Juillard⁵  Pascal Cluzel¹  Patrice Deteix²  Benoit Vendrely⁹  Christian Combe⁸  Jean Claude Aldigier³  Eric Alamartine⁴  Nicolas Rognant⁵ 

[1] AURA Auvergne, Chamalières, F-63400, France;Service de Néphrologie, Hôpital Gabriel Montpied, F-63003, Clermont Ferrand Cedex 1, France;Service de Néphrologie, Hôpital Dupuytren, Limoges Cedex, F-87042, France;Service de Néphrologie, Hôpital Nord, Saint Etienne, F-42055, France;Réseau TIRCEL, Hôpital Edouard Herriot, Lyon Cedex 03, F-69437, France;Service de Néphrologie, Hôpital Bichat, Paris Cedex 18, F-75877, France;Pôle IMER, Hospices Civils de Lyon, et EA Santé-Individus-Société, Université de Lyon, Lyon, F-69000, France;Université Victor Segalen, Bordeaux, F-33000, France;Service de Néphrologie, Transplantation, Dialyse, Centre Hospitalo-Universitaire de Bordeaux, Bordeaux, F-33000, France

关键词: CKD progression;    Cardiovascular events;    Renal cares network;    Multidisciplinary intervention;    Chronic kidney disease;   

Others  :  1082997
DOI  :  10.1186/1471-2369-14-41

 received in 2012-07-06, accepted in 2013-02-06,  发布年份 2013

【 摘 要 】

Background

Effective therapeutic strategies are available to prevent adverse outcomes in patients with chronic kidney disease (CKD) but their clinical results are hindered by unplanned implementation. Coordination of care emerges as a suitable way to improve patient outcomes. In this study, we evaluated the effect of planned and coordinated patient management within a dedicated renal care network comparatively to standard renal care delivered in nephrology departments of teaching hospitals.

Methods

This observational matched cohort study included 40 patients with CKD stage 4–5 in the network group as compared with a control group of 120 patients matched for age, sex and diabetic status. Main outcome was a composite endpoint of death from cardiovascular cause and cardiovascular events during the first year after dialysis initiation.

Results

There was no difference between the two groups neither for the primary outcome (40% vs 41%) nor for the occurrence of death from cardiovascular cause or cardiovascular events. Whereas the proportion of patients requiring at least one hospitalization was identical (83.3% vs 75%), network patients experienced less individual hospitalizations than control patients (2.3±2.0 vs 1.6±1.7) during the year before dialysis start. Patients of the network group had a slower renal function decline (7.7±2.5 vs 4.9±1.1 ml/min/1,73m² per year; p=0.04).

Conclusions

In this limited series of patients, we were unable to demonstrate a significant impact of the coordinated renal care provided in the network on early cardiovascular events in incident dialysis patients. However, during the predialysis period, there were less hospitalizations and a slower slope of renal function decrease.

【 授权许可】

   
2013 Rognant et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Couser WG, Remuzzi G, Mendis S, Tonelli M: The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 2011, 80:1258-1270.
• [2]Levey AS, de Jong PE, Coresh J: The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011, 80:17-28.
• [3]Rapport annuel: Réseau Epidémiologie et Information en Néphrologie. 2009. http://www.soc-nephrologie.org/PDF/enephro/registres/rapport_2009/rapport_2009.pdf webcite
• [4]Gilbertson DT, Liu J, Xue JL: Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol 2005, 16:3736-3741.
• [5]Kausz AT, Guo H, Pereira BJ, Collins AJ, Gilbertson DT: General medical care among patients with chronic kidney disease: opportunities for improving outcomes. J Am Soc Nephrol 2005, 16:3092-3101.
• [6]Kausz AT, Khan SS, Abichandani R: Management of patients with chronic renal insufficiency in the Northeastern United States. J Am Soc Nephrol 2001, 12:1501-1507.
• [7]Nissenson AR, Collins AJ, Hurley J, Petersen H, Pereira BJ, Steinberg EP: Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns. J Am Soc Nephrol 2001, 12:1713-1720.
• [8]Bodenheimer T: Coordinating care–a perilous journey through the health care system. N Engl J Med 2008, 358:1064-1071.
• [9]Valderrabano F, Golper T, Muirhead N, Ritz E, Levin A: Chronic kidney disease: why is current management uncoordinated and suboptimal? Nephrol Dial Transplant 2001, 16(Suppl 7):61-64.
• [10]Ruggenenti P, Perticucci E, Cravedi P: Role of remission clinics in the longitudinal treatment of CKD. J Am Soc Nephrol 2008, 19:1213-1224.
• [11]Jones C, Roderick P, Harris S, Rogerson M: An evaluation of a shared primary and secondary care nephrology service for managing patients with moderate to advanced CKD. Am J Kidney Dis 2006, 47:103-114.
• [12]Gaede P, Lund-Andersen H, Parving HH, Pedersen O: Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008, 358:580-591.
• [13]Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003, 348:383-393.
• [14]Bayliss EA, Bhardwaja B, Ross C, Beck A, Lanese DM: Multidisciplinary team care may slow the rate of decline in renal function. Clin J Am Soc Nephrol 2011, 6:704-710.
• [15]Curtis BM, Ravani P, Malberti F: The short- and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes. Nephrol Dial Transplant 2005, 20:147-154.
• [16]Goldstein M, Yassa T, Dacouris N, McFarlane P: Multidisciplinary predialysis care and morbidity and mortality of patients on dialysis. Am J Kidney Dis 2004, 44:706-714.
• [17]Hemmelgarn BR, Manns BJ, Zhang J: Association between multidisciplinary care and survival for elderly patients with chronic kidney disease. J Am Soc Nephrol 2007, 18:993-999.
• [18]Hotu C, Bagg W, Collins J: A community-based model of care improves blood pressure control and delays progression of proteinuria, left ventricular hypertrophy and diastolic dysfunction in Maori and Pacific patients with type 2 diabetes and chronic kidney disease: a randomized controlled trial. Nephrol Dial Transplant 2010, 25:3260-3266.
• [19]Laville M, Juillard L, Fave S, Deleaval P, Charlois AL, Garcia E: [Role of networks in the screening and management of chronic kidney disease]. Ann Biol Clin (Paris) 2008, 66:295-300.
• [20]Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
• [21]Hosmer DW, Lemeshow S: Applied logistic regression. New York: John Wiley & Sons; 2001.
• [22]Diggle PJ, Liang KY, Zeger SL: Analysis of longitudinal data. Oxford: Oxford University Press; 1994.
• [23]Laird NM, Ware JH: Random-effects models for longitudinal data. Biometrics 1982, 38:963-974.
• [24]Blotiere PO, Tuppin P, Weill A, Ricordeau P, Allemand H: [The cost of dialysis and kidney transplantation in France in 2007, impact of an increase of peritoneal dialysis and transplantation]. Nephrol Ther 2010, 6:240-247.
• [25]Stevens PE, O'Donoghue DJ, de Lusignan S: Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int 2007, 72:92-99.
• [26]Miller LM, Hopman WM, Garland JS, Yeates KE, Pilkey RM: Cardioprotective medication use in hemodialysis patients. Can J Cardiol 2006, 22:755-760.
• [27]Sood MM, Battistella M, Lok CE: Patterns of cardioprotective medication prescription in incident hemodialysis patients. Int Urol Nephrol 2009, 41:1021-1027.
• [28]Tonelli M, Bohm C, Pandeya S, Gill J, Levin A, Kiberd BA: Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. Am J Kidney Dis 2001, 37:484-489.
• [29]Cooper B, Branley P, Bulfone L: A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 2010, 363:609-619.
• [30]Devins GM, Mendelssohn DC, Barre PE, Binik YM: Predialysis psychoeducational intervention and coping styles influence time to dialysis in chronic kidney disease. Am J Kidney Dis 2003, 42:693-703.
• [31]Remuzzi G, Benigni A, Remuzzi A: Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 2006, 116:288-296.